Neuronasal was founded to create value for patients and investors by in-licensing and developing drugs to treat acute brain injuries and disease. We plan to develop each of our drugs to proof-of-concept and then enter into strategic partnerships or trade sales. The company's initial intellectual property was licensed from HealthPartners of Minneapolis and from Cornell University. Neuronasal's first two products are repurposed ...
Neuronasal was founded to create value for patients and investors by in-licensing and developing drugs to treat acute brain injuries and disease. We plan to develop each of our drugs to proof-of-concept and then enter into strategic partnerships or trade sales. The company's initial intellectual property was licensed from HealthPartners of Minneapolis and from Cornell University. Neuronasal's first two products are repurposed off-patent drugs, deferoxamine and N-acetyl cysteine, that we will deliver with existing intranasal delivery devices in clinical trials for concussion and intracerebral hemorrhage
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.